tiprankstipranks
CVRx reiterates plans to discuss post-market phase results of BeAT-HF trial
The Fly

CVRx reiterates plans to discuss post-market phase results of BeAT-HF trial

CVRx reiterated plans to discuss the preliminary results of the post-market phase of the BeAT-HF trial at the second annual Technology and Heart Failure Therapeutics conference on Tuesday, March 21, 2023 at 10:58 am Eastern Time in Boston. These results will be presented by Dr. Michael Zile, Professor of Cardiology at the Medical University of South Carolina/ Additionally, CVRx will sponsor a symposium, "Baroreflex Activation Therapy in HFrEF: New Insights from the BeAT-HF Study", at the THT 2023 conference starting at 12:30 pm ET. Dr. Zile’s slides and the slides presented at the symposium will be filed on a Form 8-K concurrent with Dr. Zile’s presentation.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on CVRX:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles